Schizophrenia is the disease that becomes extremely widespread in the modern world. People suffer from this disease more and more and there are great many of reasons for this. The increase of schizophrenia cases in the world leads to the growth of the interest to disease medication and other ways of treatment. Cheng-Fang et al (2008) conducted a research devoted to the influence of quality of life on schizophrenia treatment in the combination with atypical antipsychotics. The results showed that the level of quality of life influenced people with schizophrenia diagnosis negatively. The attraction of patients’ attention to the quality of life was negatively perceived as people with schizophrenia are in depressed condition and perceive everything negatively (Cheng-Fang et al, 2008). The other research related to the medication and the level of quality of life was conducted by Norholm and Bech (2007). They managed to prove that the general condition and better outcomes for schizophrenia patients can be reached via improving of the quality of life of patients with schizophrenia diagnosis (Norholm & Bech, 2007).
These two primary sources can be the background for our research as it is important to know whether the treatment in the combination of improved quality of life and atypical antipsychotics more effective than just commonly accepted atypical antipsychotics medication. The research will be conducted by means of the experiment and the comparison of results in two groups. The main purpose of the research is to prove that atypical antipsychotics medication supported with the improvement of quality of life in general is more effective treatment for patients with schizophrenia diagnosis.
The experiment will last for 2 weeks after that the received results will be evaluated and compared.The experiment is going to be conducted on 30 patients who suffer from schizophrenia. The participants will be divided into two groups. The patients will be examined in one of the local hospitals that deal with the schizophrenia problems. 30 participants will be divided into two groups. One group will receive atypical antipsychotics medication only, while another will receiver the same atypical antipsychotics medication and will experience the general improvement of quality of life. This improvement can be achieved by means of improving accommodation conditions and better nourishment. The participants will be selected randomly, without relating to sex and age signs.
The participants of the experiment will be tested before the beginning of the experiment conduction and after its termination. Moreover, the participants of these two groups will be watched through the whole experimental procedure. The main peculiarity of the experiment will be to conduct the same tests at the beginning of the experiment ad at the end to consider the changes in patients’ perception of the world. No any outside factors, like relatives’ visits, will be allowed.
The main measure of the experiment is the results of the test the participants of the experiment will come through at the beginning and at the end. The results will be compared and evaluated to make a conclusion. The results will allow use state which group is more successful, whether the first one that received only atypical antipsychotics medication or the second one that combined the medication with the improving of the life quality. Moreover, the indirect information will be received whether patients with schizophrenia treatment restricted from their relatives recover slower or with the same frequency.
Plans for analysis
The test results collected before and after the experiment will be summarized and presented in the form of statistical data. The information will be analyzed according to each of the participants and summarized one on the whole group. The results will be recorded in the variable of ratio, relying to the results of the tests. Basing on hypothesis stated at the beginning we expect that the parents who received atypical antipsychotics medication and were subjected to the improving of quality of life will show better progress in disease combat.
The purpose of the proposal study is to determine that people with combined medication and mental treatment will show better results in schizophrenia combat. The group of 30 patients will be taken for the experiments. The two groups will be created with the aim to subject them to different kinds of treatment. The main value of the experiment is that the results will be significant and will allow either support or reject the offered hypothesis, in case it appears to be null.
The main limitation of the research is that the selection of the participants is conducted randomly, without relaying to the previous quality of live and age group. The results can be misrepresented is the quality of life of the participants of the experiment used to live in will be diametrically opposite. Moreover, the experiment does not presuppose the questionnaire filling up by patients’ relatives. This could help in forming groups and understanding the level of the quality of life that should be achieved.
Cheng-Fang, Y., Chung-Ping, C., Chi-Fen, H., Ju-Yu, Y., Chih-Hung, K., & Cheng-Sheng, C. (2008). Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission. Bipolar Disorders, 10(5), 617-624. Web.
Norholm, V., & Bech, P. (2007). Quality of life assessment in schizophrenia: Applicability of the Lehman Quality of Life Questionnaire (TL-30). Nordic Journal of Psychiatry, 61(6), 438-442. Web.